Accelerated Clinical Trial Agreement Announcement
SPRI is pleased to announce that we are now part of the Accelerated Clinical Trial Agreement program (ACTA). This allows us to significantly reduce contract negotiation time and get your project up and running faster.
Chuck Griffith, SPRI’s CFO states, “We are pleased to be part of the Accelerated Clinical Trial Agreement program. After a thorough internal review, we find these agreements to be extremely well written and to fairly address the interests of all parties. SPRI will always be willing to review any agreement based on the needs of the individual parties involved, but using these agreements as a starting point will make that process much easier allowing us to devote more time to our mission of Bringing together science, technology and patients to promote health on a global scale.”